REFRACTORY MELANOMA
Clinical trials for REFRACTORY MELANOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY MELANOMA trials appear
Sign up with your email to follow new studies for REFRACTORY MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine trains immune system to fight tough melanoma
Disease control Recruiting nowThis study tests a new treatment called DOC1021 for people with advanced melanoma that has not responded to standard therapy. DOC1021 is a personalized vaccine made from a patient's own blood and tumor cells, designed to teach the immune system to attack the cancer. The trial wil…
Matched conditions: REFRACTORY MELANOMA
Phase: PHASE1, PHASE2 • Sponsor: Diakonos Oncology Corporation • Aim: Disease control
Last updated Jul 02, 2026 03:00 UTC
-
New cancer drug IACS-6274 enters early human testing
Disease control Recruiting nowThis early-phase trial is testing a new drug called IACS-6274, either alone or combined with other cancer drugs, in 54 adults with advanced solid tumors (such as melanoma, ovarian, or head and neck cancers). The main goal is to find the safest dose and understand side effects. Th…
Matched conditions: REFRACTORY MELANOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Supercharged immune cells take on hard-to-treat melanoma in early trial
Disease control Recruiting nowThis early-phase study tests a new type of cell therapy for people with advanced melanoma that has not responded to standard treatments. The therapy uses a patient's own immune cells (NK cells) that are engineered in the lab to recognize and attack a protein called PRAME found on…
Matched conditions: REFRACTORY MELANOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC